Head-to-head · Cost-Efficiency Index
Modern Age vs Thryve
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Modern Age
Cost-first shoppers who want nYC-based patients who want GLP-1 prescribing bundled into an in-person longevity/aesthetics practice.
Visit Modern AgeThryve
Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Visit ThryveThe verdict
Modern Age takes it, leading the Cost-Efficiency Index 38 to 22. Modern Age is a single-location, in-person longevity clinic on New York's Upper East Side that prescribes real branded GLP-1s (Wegovy, Ozempic, Mounjaro, Rybelsus) as part of a broader anti-aging practice. Thryve still earns a C — Not currently recommendable — include only for completeness while the underlying site remains this undocumented.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Modern Age.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Modern Age | Thryve |
|---|---|---|
| Cost-Efficiency Index | 38/100 | 22/100 |
| Semaglutide / mo | $900/mo (plus a separate fee, brand-name) | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Tirzepatide / mo | $1,600/mo (plus a separate fee, brand-name) | $99/mo (drug not specified — site never names semaglutide or tirzepatide) |
| Semaglutide / yr (modeled) | $10,800 | $1,188 |
| Tirzepatide / yr (modeled) | $19,200 | $1,188 |
| Coverage | Coverage not published | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #534 | #539 |
Modern Age
38/100Where the value is
- Prescribes real branded medications (Wegovy, Ozempic, Mounjaro) rather than compounded alternatives
- In-person clinical oversight with blood draws and bone scans
- Transparent (if wide-ranging) pricing disclosure of the $900-1600/month medication cost
The tradeoffs
- Single physical location in NYC only -- not usable by the vast majority of a nationwide audience
- Significantly more expensive than compounded-GLP-1 telehealth competitors
Thryve
22/100Where the value is
- A low headline price is advertised, if a reader wants to investigate directly
The tradeoffs
- Never names which drug is being sold — no mention of semaglutide, tirzepatide, or any other active ingredient anywhere on the site
- No dose, no state-coverage list, no named clinician, and no named pharmacy found anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.